Sevelamer Carbonate Tablets(Ref.Brand: Renvela®(US & EU) Generics

Form: Tablet

Strength: 400 mg , 800mg

Reference Brands:

Category: Nephrology

Sevelamer Carbonate Tablets are a leading phosphate binder used to control hyperphosphatemia in chronic kidney disease (CKD) patients undergoing dialysis. Unlike calcium-based binders, Sevelamer carbonate reduces serum phosphate levels without increasing calcium load, minimizing the risk of vascular calcification. It is widely prescribed in nephrology for effective phosphate management in ESRD (end-stage renal disease). Marketed under the brand name Renvela® in the US and EU, Sevelamer Carbonate Tablets are essential for renal care protocols. We offer high-quality, GMP-compliant bulk supply for global Pharma B2B procurement, ideal for hospital tenders, dialysis centers, and private label pharmaceutical companies.